Fuqiang Cui
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Health top 1%
- Vaccine Coverage and Hesitancy
Papers in
- Epidemiology 109
- Hepatitis B Virus Studies 91
- Liver Disease Diagnosis and Treatment 19
- Influenza Virus Research Studies 13
- Hepatology 74
- Hepatitis Viruses Studies and Epidemiology 50
- Hepatitis C virus research 47
- Co-authors
- Fuzhen Wang (41 shared papers)Hui Zheng (32 shared papers)Ning Miao (24 shared papers)Xiaofeng Liang (22 shared papers)Tianshuo Zhao (29 shared papers)Xiaojin Sun (16 shared papers)Qing‐Bin Lu (31 shared papers)Guomin Zhang (18 shared papers)
- Journals
- Vaccine (25 papers)Human Vaccines & Immunotherapeutics (10 papers)Journal of Medical Virology (9 papers)Vaccines (6 papers)PLoS ONE (5 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Fuqiang Cui
134 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 120
- Hepatology 1.2k
- Health 489
- Epidemiology 1.4k
- Modeling and Simulation 158
- Infectious Diseases 528
Countries citing papers authored by Fuqiang Cui
This map shows the geographic impact of Fuqiang Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuqiang Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuqiang Cui more than expected).
Fields of papers citing papers by Fuqiang Cui
This network shows the impact of papers produced by Fuqiang Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuqiang Cui. The network helps show where Fuqiang Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Fuqiang Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 244 | |
| 2 | 2021 | 125 | |
| 3 | 2020 | 105 | |
| 4 | [A sero-epidemiological study on hepatitis C in China]. | 2011 | 80 |
| 5 | 2014 | 77 | |
| 6 | 2022 | 63 | |
| 7 | 2006 | 63 | |
| 8 | 2019 | 57 | |
| 9 | 2023 | 55 | |
| 10 | 2009 | 49 | |
| 11 | 2014 | 43 | |
| 12 | 2015 | 41 | |
| 13 | 2019 | 40 | |
| 14 | 2013 | 37 | |
| 15 | 2010 | 35 | |
| 16 | 2023 | 35 | |
| 17 | 2011 | 32 | |
| 18 | 2013 | 31 | |
| 19 | 2013 | 31 | |
| 20 | 2013 | 30 |
About Fuqiang Cui
Fuqiang Cui is a scholar working on Epidemiology, Hepatology, Infectious Diseases, Health and Modeling and Simulation, having authored 145 papers that have together received 2.2k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (91 papers), Hepatitis Viruses Studies and Epidemiology (50 papers), Hepatitis C virus research (47 papers), Vaccine Coverage and Hesitancy (36 papers), Liver Disease Diagnosis and Treatment (19 papers), Influenza Virus Research Studies (13 papers), Viral gastroenteritis research and epidemiology (13 papers) and COVID-19 epidemiological studies (13 papers). The work is most often cited by research in Hepatology (1.2k citations), Health (489 citations), Epidemiology (1.4k citations), Modeling and Simulation (158 citations) and Infectious Diseases (528 citations). Fuqiang Cui has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Fuzhen Wang, Hui Zheng, Ning Miao, Xiaofeng Liang, Tianshuo Zhao, Xiaojin Sun, Qing‐Bin Lu, Guomin Zhang, Li Li and Shengli Bi. Their work appears in journals such as Vaccine, Human Vaccines & Immunotherapeutics, Journal of Medical Virology, Vaccines and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.